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ABSTRACT 
Diabetes has become a dreadful disease in this era. It is also described in Ayurvedic texts in terms 
of Madhumeha. Diabetes Mellitus is disease known from the dawn of civilization. Sedentary life 
style, lack of exercise, faulty dietary habits, improper medication & urbanization precipitate the 
disease. It is estimated that the total number of people with diabetes will rise from 171 million in 
2000 to 366 million by 2030. As per WHO report, currently half a billion people (12% of the 
world’s population) are considered obese. As obesity is the one of the root cause of the disease. 
Observing the current status of prevalence and morbidity of the disease proper medication for the 
disease is mandatory. In the present study, Madhumeha Nashini Gutika a herbomineral 
preparation and Darvyadi Kwath (both mentioned in Ayurvedic texts) were selected for clinical 
trial. The study comprised of a series of 60 patients of Madhumeha. The patients were selected 
from OPD and IPD of Kayachikitsa of Rishikul Government Ayurvedic P.G. College & Hospital. After 
evaluating the total effect of therapies it was observed that the Madhumeha Nashinh Gutika & 
Darvyadi Kwath (Combined therapy) provided better relief to the patients of Madhumeha in 
comparison to single group therapy. 
KEYWORDS: Madhumeha, Obesity, Madhumeha Nashinh Gutika, Darvyadi Kwath. 
INTRODUCTION
Each year about 17 million people die 
prematurely as the result of the global epidemic of 
largerly preventable diseases or life style diseases. 
According to WHO, world deaths from life style 
diseases will double by 2015 unless all out efforts are 
taken to combat them.  
 According to International Diabetes Federation 
61.3 million people in India have diabetes in 2011 that 
figure is projected to rise to 101.2 million by 2030. IDF 
revealed that India has more diabetes than the US. 
India has rank second in the world in diabetes 
prevalence, just behind China. 
 India has more than 40 million diabetic 
patients, more than any other country in the world. 20 
% of diabetic patients live in India. Type 1 DM is 
relatively rare in our country and less than 2% of the 
diabetics in India are having Type 1 DM, whereas more 
than 96% of the diabetics have Type 2 DM. Prevalence 
of Type 2 DM which was about 2% in early seventies 
has sharply risen to more than 8% in late nineties in 
urban areas in our country.[1] 
Diabetes mellitus (DM) is not a single disease 
but a group of metabolic disorders, characterized by 
hyperglycaemia, and finally resulting in the appearance 
of various complications (macro and micro 
angiopathy). Blood glucose levels are controlled by a 
complex interaction of multiple chemicals and 
hormones in the body, including the hormone insulin 
made in the beta cells of the pancreas. Diabetes 
mellitus refers to the group of diseases that lead to high 
blood glucose levels due to defects in either insulin 
secretion or insulin action.  
Diabetes develops due to a diminished 
production of insulin (in type 1) or resistance to its 
effects (in type 2 and gestational). Both lead to 
hyperglycemia, which largely causes the acute signs of 
diabetes: excessive urine production, resulting 
compensatory thirst and increased fluid intake, blurred 
vision, unexplained weight loss, lethargy, and changes 
in energy metabolism. Monogenic forms, e.g. MODY, 
constitute 1-5 % of all cases.  
Diabetes mellitus is classified as,[2] 
1) Type 1 DM 
2) Type 2 DM 
3) Other specific type of diabetes mellitus (genetic 
defects of beta cell function and insulin action, 
disease of exocrine pancreas, endocrinopathies, 
drug induced etc.) 
4) Gestational diabetes mellitus.  
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 Among lifestyle diseases, Diabetes is on 
increasing trends to the tune of lifestyle epidemics 
globally, but largely in Asian sub continent. The centric 
point in the causation of the disease is derangement of 
Agni (Metabolic fire) and Dhatuposhan (Altered cells 
homoeostasis). Severe lifestyle related risk factors are 
needed to be modified along with the invention of few 
potent Ayurvedic medicines and herbs to prevent at 
primary as well as secondary level and for treatment of 
the disease concerned. 
In Ayurveda Madhumeha (diabetes mellitus) is 
described among the 20 sub types of Prameha and is 
predominantly a Vatika disease. Ayurveda believes that 
it occurs mainly due to Medodusti. This Medodusti 
vitiate Mansa, Rakta, Kleda and Ojas. All the Dhatus and 
Malas & all three Doshas are involved in the disease 
procedure. In sutra 17, ‘Kiyantahshirsia Adhyay’ charak 
says that the disease leads due to Ojodusti, when a 
person eats a rich diet with lack of exercise, it leads to 
vitiation of Ojo, which Avrits the Mutravaha srotas 
precipitating to Prameha.[3] It seems to be the 
description of autoimmune diabetes mellitus. In Nidan 
4, ‘Prameh Nidan Adhyay’ and Chikitsa 6 ‘Prameh 
Chikitsa Adhyay’ the pathogenesis starts with vitiation 
of Medas. According to Charak the Manasdoshas - Rajas 
and Tamas have a very great adverse effect on the body 
and three Doshas also.[4] 
In Ayurvedic literature the disease has been classified 
as under: 
 Etiological classification 
 Apathyanimittaja Prameha– Non-Insulin 
Dependent Diabetes Mellitus (NIDDM) -Due to 
over eating and lack of exercise. 
 Sahaja Prameha -Insulin Dependent Diabetes 
Mellitus (IDDM) – It highlights the genetic pre-
disposition of disease. 
 Clinico-pathological classification (Doshic) 
 Kaphaja Prameha (Early diabetes) 
 Pittaja Prameha (Acute diabetes) 
 Vataja Prameha (Chronic diabetes)  
 Therapeutic classification (Based on body 
constitution)  
 Sthula Pramehi (Obese diabetics) 
 Krisha Pramehi (Asthenic diabetics) 
 Prognostic classification (Based on Sadhya 
sadhyata) 
 Easily manageable – Apathyanimittaja, sthula, 
kaphaja 
 Palliative – Pittaja prameha 
 Unmanageable – Sahaja, krisha, vataja 
 Though, the discovery of Insulin and other 
hypoglycemic drugs has a great achievement of modern 
medical science, but the hazardous side effects of 
hypoglycemics after long term used are incurable and 
hence an ideal therapy is still obscure. The Ayurvedic 
management of Diabetes aims not only to achieve a 
strict glycemic control but also to treat the root cause 
of the disease. For it various modalities of treatment 
are developed which depends upon the underline 
pathology.  
 Thus it is the demand of today’s era to explore 
the better treatment options from the most time tested 
system of medicine. Ayurveda advocates healthy life 
style both to prevent and manage the life style diseases. 
“Swathasya swathya rakshanama aaturasya vikara 
prashamanam”.  
 It also prescribes the dietary and other life 
style modifications in terms of exercise etc, besides 
recommending drugs for the same. Ayurvedic 
medications as proved repeatedly have multi-factorial 
effects (Deepana, Pachana, Rasayana etc). Besides 
countering the raised glucose levels in the blood they 
also nourishes the body tissues, have rejuvenative 
effect on the brain tissue of chronic diabetic state. They 
ensure better sustainability to the tissues of the body 
because of their Rasayana (anti-oxidant action) 
property as there is no such action reported from the 
conventional system of medicine. As faulty dietary 
habits are one of the most important reasons for type-2 
diabetes, Ayurvedic dietary recommendations ensures 
no further worsening of diabetic state. 
  To further support the above said facts and to 
explore a new combination of Ayurvedic herbs in 
modern era of ever growing diabetes mellitus, the 
study was planned to evaluate the efficacy of Ayurvedic 
herbal drug combination. 
 In the present study, a ‘Madhumeha Nashini 
Gutika’[5] herbomineral preparation and ‘Darvyadi 
Kwath’ [6] are selected for clinical trial. 
Aims and objectives of the study are to study 
the etiopathogenesis of Madhumeha to compare the 
effect of Madhumeha Nashini Gutika & Darvyadi Kwath 
and to identify the best, effective and safe treatment in 
Ayurveda for Madhumeha. 
MATERIAL AND METHODS  
Selection of the patients  
The study comprised of a series of 60 patients 
of Type 2 DM. The patients were selected from OPD and 
IPD of Kayachikitsa of Rishikul Government Ayurvedic 
P.G. College. These patients are randomly divided in 3 
groups 20 patients in each, on the basis of inclusion and 
exclusion criteria depending upon Fasting & PP Blood 
Sugar with detailed clinical history, physical 
examination and other necessary / desired 
investigation. Some cases were hospitalized for 
investigation and some were taken as OPD patients. 
The cases were recorded with help of a special 
proforma prepared for this purpose.  
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Selection of drug 
1. Madhumeha Nashini Gutika (Rasamrit) 500mg TDS 
with luke warm water after meal. 
2. Darvyadi Kwath (Charak chi. 6/26) 40ml BD after 
meal. 
Ingredients of ‘Madhumeh Nashini Gutika’ 
(Rasamrit)  
1. Trivanga Bhasma (Nag, Vanga & Yashad bhasma) 
2. Leaf of Gudmar (Gymnema Sylvestre) 
3. Leaf of Nimb (Azardichata Indica)  
4. Shilajeet  
 The powder forms of these drugs are taken in 
the ratio of 1:3:3:6 and mixed with each other, then 
tablet of 500mg is made and let it to dry. 
Properties of the contents  
Contents  Sanskrit 
Name  
Latin 
Name 
Rasa Veerya Vipak Doshaghnta Rogaghnta  
1.(Trivanga 
Bhasm) -     
Nag  
Nag  Plumbum Tikt, Katu 
Madhur, 
Lavan 
Ushana  Katu  Kaphvatanashak  Pramehnashak, 
Aamvatnashak, 
Panduhar etc.  
Vanga Vanga  Stannum Tikt, katu, 
kashay, 
aml 
Ushana Katu  Kaphpittahar Pramehhar, 
Krimihar, 
Panduhar etc. 
Yashad Yashad  Zincum  Tikt, katu, 
kashay 
Sheet  Katu  Kapha -pitta 
nashak, Vatahar  
Pramehhar, 
Panduhar, Kas-
shwashar  
2.Gudmar Meshshringi Gymnema 
Sylvestre 
Tikta, 
kashay 
Ushana  Katu Kaph-vata 
nashak 
Pramehhar, 
Kushthar etc. 
3. Nimb  Nimb Azardichata 
Indica 
Tikt, 
Kashay 
Sheeta  Katu  Kapha - Pitta 
nashak 
Kushthagn, 
Kandughn etc. 
4.Shilajeet Shilajatu Asphaltum 
Punjabinum 
Tikt, lavan  Sheet  Katu  Tridoshshamak Mutrarognashak, 
Medonashak etc.  
 Ingredients of Darvyadi Kwath 
Name of drug Latin name Chemical constitutes Ras  Veerya  vipak Doshaghnta 
Daruharidra Berberis 
aristata 
 Berberin  
 
Tikta Ushana  Katu  Kapha pitta 
nashak 
Devadaru Cedrus 
deodara 
Terpenoids, Flavonoids 
and Glycosides 
Tikta, Katu  Ushana Katu  Kapha pitta 
nashak 
Haritki  Terminalia 
chebula 
 
Tannins, 
anthraquinones and 
polyphenolic 
compounds 
Pancaras 
except Lavan 
Ushana Madhur  Tridoshahar  
Bibhitki 
 
Terminalia 
bellirica 
Gallic acid, tannic acid 
and glycosides 
Kashaya  Ushana  Madhur  Kapha shamak 
Amalki Emblica 
officinalis 
Ascorbic acid tannins, 
gallic acid. 
Pancharasa, 
except Lavana 
Sheeta  Madhura  Tridoshhar  
Musta  Cyperus 
rotundus  
Volatile Oil Tikta, Katu, 
Kashay 
Sheeta  Katu  Pitta shamak 
Drug Dosages 
1. Madhumeha Nashini Gutika (Rasamrit) 
Every tablet of ‘Madhumeha Nashini Gutika’ is 
consist of 500mg wt. Patients are asked to take 
‘Madhumeha Nashini Gutika’ 1.5gm/day in divided 
dose, i.e. 3 times in a day with Luke warm water for 3 
months. 
 
 
2. Darvyadi Kwath (Charak chi. 6/26) 
Patients are dispensed Darvyadhi Kwath in raw 
form and asked to prepare it by following method: 5gm 
of raw Kwath is taken and make it boil with 4 cup of 
water (about 160 ml). After some time when 1 cup of 
water (about 40 ml) is remaining then after filtering it 
should be used after meal. 
Duration of study – 90 days, Follow up – 15 days. 
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Groups for drug trial 
GROUP I - Madhumeha Nashini Gutika 
GROUP II - Darvyadi Kwath 
GROUP III - Madhumeha Nashini Gutika & 
Darvyadi Kwath 
 Inclusion criteria 
 Diagnosed patients without any complication are 
included. 
 Age between 16-60 years. 
 BSF – upto 200 mg/dl 
 BSPP – upto 300 mg/dl 
Exclusion criteria 
 Patient having DM type 1 
 Patient having complication of diabetes 
 Any other serious medical & surgical ill patients 
are excluded. 
Investigations  
 Hb%, TLC, DLC, ESR 
 Urine – Routine & Microscopic 
 Lipid profile 
 HbA1C 
 X ray chest 
These investigations were done in all the patients 
before and after completion of treatment to rule out 
any other pathological condition. 
 BS- F & PP 
 It will be carried out before trial and after each 
follow up i.e. 15 days. 
Parameter of assessment 
1. Subjective assessment 
2. Objective assessment 
1. Subjective parameter of assessment 
The assessment of the drug trial is done the basis of 
improvement in the symtoms during and after trial. 
The symptoms are graded as per their severity. The 
detail assessment of clinical signs and symptoms are 
discussed below:  
(1) Polyuria  
3-6 times/day, rarely at night 0 
6-9 times/day, 0-2 times at night 1 
9-12 times/day, 2-4 times at night  2 
>12 times/day, >4 times at night      3 
(2) Polydipsia 
Feeling of thirst 7- 9 times/24 hrs  0 
Feeling of thirst 9-11 times /24hrs  1 
Feeling of thirst 11-13 times/24hrs  2 
Feeling of thirst>13 times/24 hrs   3 
(3) Polyphagia  
Regular (usual diet schedule) 0 
 Slightly increased (1-2 meals) 1 
Moderately increased (3-6 meals)  2 
Markedly increased (>6 meals) 3 
 (4) Weakness  
Can do routine exercise/work  0 
Can do moderate exercise with hesitancy 1 
Can do mild exercise only, with difficulty 2 
Cannot do mild exercise too   3 
(5) Muscles cramps  
No cramps 0 
Cramps after walking 2 km 1 
Cramps after walking 1&1/2 Km   2 
Cramps after walking 1 Km   3 
Unable to walk even ½ km  4 
(6)Libido  
Normal 0 
Decreased frequency with normal 
performance  
1 
Decrease frequency with insufficiency 2 
No sexual stimulation at all 3 
(7) Joint pain  
No pain 0 
Pain in joint, routine movements normal 1 
Pain in joint, slight limitations of 
movements 
2 
Pain in joint, limitations of movements 
with much reduced activity 
3 
(8) Panduvaranmutrata 
Crystal clear fluid 0 
Faintly cloudy or hazy with slight turbidity 1 
Turbidity clearly present and newsprint 
easily read through test tube  
2 
Newsprint not easily read through test 
tube  
3 
2. Objective parameter of assessment 
The assessment will be done on the basis of 
change in Blood Sugar F & PP in each follow up and at 
the end of trial. 
Statistical analysis Mean, percentage relief, S.D, ‘t’ and ‘p’ values were calculated. Paired ‘t’ test was used for 
calculating the ‘t’ value in the paired data.  
Assessment of overall effect of the therapy 
First percentage improvement of individual patient was calculated as shown below:  
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All the B.T. score of the above mentioned symptoms & biochemical parameters of the patient were added. All the 
A.T. score of the above mentioned symptoms & biochemical parameters of the patient were added. Overall 
percentage improvement of each patient was calculated by the following formula:  
 Total BT-Total AT × 100 
        Total BT  
 The result thus obtained from individual patient was categorized according to the following grades:  
Control of the disease 100% relief, Marked improvement ≥75% relief  
Moderate improvement ≥50% upto 74% relief, Mild improvement ≥25% upto 49% relief 
 No improvement ≤25% relief 
 Results and Discussion 
Table 1: Distribution of signs and symptoms in 60 patients of Diabetes Mellitus  
Symptoms  No. of patients in 
Group-I 
No. of patients in 
Group-II 
No. of patients 
in Group-III 
Total  Percentage  
Polyuria  12 10 8 28 46.7% 
Polydipsia  9 8 8 25 41.7% 
Polyphagia  12 7 5 24 40% 
Panduvaran mutrata  4 4 5 13 21.7% 
Weakness  17 12 16 45 75% 
Joint pain 11 14 8 33 55% 
Muscles cramp 11 10 14 35 58.3% 
Libido  4 3 6 13 21.7% 
Table 2: Assessment of result in symptoms of diabetic patients in GROUP – I 
Symptoms   BT  FU1 FU2 FU3(AT) % relief  ‘t’  P 
Polyuria  2.05+1.81 1.6+.68 0.9+.97 0.9 + 1.07 56 4.38  <.001H.S 
Polydipsia  1.6+1.87 1.1+0.90 0.65+1.26 0.5 + 1.41 68.7 3.49  <.01 
Polyphagia  1.5+1.74 1.6+1.74 .85+.94 .55 + 1.15 63.3 3.68  <.01 
Weakness   2.75+1.41 1.85+1.12 1.1+1.17 0.9 + 1.14 67.2 7.19  <.001H.S 
Muscles Cramps   1.6+1.57 1.25+.58 0.75+.89 0.4 + 1.13 75 4.53 <.001H.S 
Libido   0.4+.83 0.2+0.53 0.15+.65 0.15 + .67 62 2.33 <.05 
Joint pain  1.9+1.86 1.45+.83 0.95+1.25 0.8 + 1.14 57.8 4.27 <.001H.S 
Panduvarn mutrata  0.45+.82 0.2+.31 0.1+.31 0.1 + 0.73 77 2.134 <.05 
BT-Before Treatment, AT- After Treatment, FU- Follow up, Mean+SD 
Table 3: Assessment of result in blood sugar fasting and post prandial cases in GROUP – I 
 B.T.  FU1  FU2 FU3 (AT) % relief  ‘t’  P 
BSF 149.06+46.68 127.58+ 12.86 115.7+16.75 106.24 + 36.49 28.7 4.02 <.001H.S 
BSPP 220.68+78.99 196.35+23.90 180+30.48 174.37 + 51.50 20.9 4.01 <.001H.S 
Table 4: Assessment of results in symptoms of diabetic patients in Group- II 
Symptoms   BT  FU1 FU2 FU3(AT) % relief  ‘t’  P 
Polyuria  0.95+ 1.03 0.50+.91 0.35+.68 0.15+ .84 84.2% 2.39  <.05 
Polydipsia  0.95+1.35 0.6+0.56 0.5+.61 0.25+.95 73.6% 3.27 <.01 
Polyphagia  1.25+1.58 0.85+.59 0.5+.93 0.3+1.26 76% 3.35 <.01 
Weakness   1.75+1.84 .85+1.12 0.65+1.10 0.15+1.64 71.4% 4.36  <.001H.S 
Cramps on walking   1.45+1.79 0.9 +.60 0.65+.1.10 0.3+1.31 79.3% 3.90 <.001H.S 
Libido   0.5+.88 0.3+0.78 0.25+.89 0.05+ .84 90% 2.39 <.05 
Joint pain  1.85+1.22 1.2+1.01 0.15+.68 0.05+.84 97.2% 4.09 <.001H.S 
Panduvarn mutrata  .85+.1.34 0.7+.37 0.5+ .47 0.25+1.07 70.5% 2.50 <.05 
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Table 5: Assessment of result in blood sugar fasting and post prandial cases in GROUP – II 
 B.T.  FU1  FU2 FU3 (AT) % relief  ‘t’  P 
BSF 158.05+20.42 150+ 3.80 148.35+7.05 140.15 + 6.78 11.3% 4.64 <.001H.S 
BSPP 215.45+33.24 211.85+6.71 211.6+4.86 210.45 + 3.6 2.3% 3.86 <.01 
Table 6: Assessment of result in symptoms of diabetic patients in GROUP – III 
Symptoms   BT  FU1 FU2 FU3(AT) % relief  ‘t’  P 
Polyuria  1.9 +1.83 1.3+.607 0.8+1.14 0.3+ 1.64 84.2% 4.36  <.001H.S 
Polydipsia  1.6+1.87 1.0+0.83 0.75+1.16 0.35+1.59 78.1% 3.50 <.01 
Polyphagia  1.35+1.75 0.9+.84 0.6+1.09 0.25+1.55 81.4% 3.15 <.01 
Weakness   2.45+1.76 1.8+1.12 1.2+1.04 0.35+1.64 85.7% 5.71  <.001H.S 
Cramps on walking   2.75+1.71 1.80+.91 0.9+.1.52 0.4+ 1.63 85.4% 6.39 <.001H.S 
Libido   0.4+.88 0.35+0.53 0.25+.37 0.15 + .36 62.5% 2.79 <.05 
Joint pain  1.85+1.92 1.2+1.01 0.45+1.67 0.2 + 1.80 89.1% 4.09 <.001H.S 
Panduvarn mutrata  1.0+.1.6 0.65+.67 0.3+.1.24 0.15+ 1.43 85% 2.64 <.02 
Table 7: Assessment of result in blood sugar fasting and post prandial cases in GROUP – III 
 B.T.  FU1  FU2 FU3 (AT) % relief  ‘t’  P 
BSF 172.04+42.32 153.8+ 17.94 140.1+17.86 124.85 + 27.67 27.4% 7.62 <.001H.S. 
BSPP 268.4+64.73 237.4+25.96 217.2+33.57 191.5+ 45.14 28.6% 7.61 <.001H.S 
Table 8: Effect of drug trial on other biochemical values in Group III 
Biochemical values (mg/dl) B.T A.T S.D  ‘t’  P 
1. S.Cholesterol 209.65 208.15 1.97 3.35 <.01S 
2. S.Triglycerides 171.7 169.2 2.97 3.08 <.01S 
3. S.HDL 42.35 41.45 1.28 3.12 <.01S 
4. S.LDL 154.35 153.15 1.56 3.42 <.01S 
5. S.VLDL 39.25 38.3 1.31 3.24 <.01S 
6. S.Creatinine 1.04 1.01 1.06 2.78 <.02S 
7. Blood urea 37.35 36.45 1.10 3.65 <.01S 
Table 9: Comparative assessment of % relief on various symptoms 
Symptoms  % Relief in Group I % Relief in Group II % Relief in Group III 
Polyuria  56% 84.2% 84.2% 
Polydipsia  68.7% 73.6% 78.1% 
Polyphagia  63.3% 76% 81.4% 
Weakness  67.2% 71.4% 85.7% 
Cramps on walking  75% 79.3% 85.4% 
Libido  62% 90% 62.5% 
Joint pain 57.8% 97.2% 89.1% 
Panduvarnmutrata 77% 70.5% 85% 
Table 10: Comparative improvement of symptoms in various Groups 
   GROUP – I  GROUP – II  GROUP – III 
Symptoms  Marked  Moderate Mild Marked  Moderate Mild Marked  Moderate Mild 
Polyuria  - 56% - 84.2% - - 84.2% - - 
Polydipsia  - 68.7% - - 73.6% - 78.1% - - 
Polyphagia  - 63.3% - 76% - - 81.4% - - 
Weakness  - 67.2% - - 71.4% - 85.7% - - 
Muscles Cramps 75% - - 79.3% - - 85.4% - - 
Libido  - 62% - 90% - - 62.5% - - 
Joint pain - 57.8% - 97.2% - - 89.1% - - 
Panduvarn mutrata 77% - - - 70.5% - 85% - - 
DISCUSSION 
In view of Ayurveda, indulgence in faulty life 
style creates a number of diseases where along with 
the medical interventions; modifications in life style, 
dietary stuffs & habits plays important role in 
managing or reversing the diseases process. 
Apathyanimittajja prameha mentioned in the Ayurvedic 
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texts has much similarity to the type-2 diabetes 
mellitus in terms of its etiology, etiopathpogenesis, and 
presentation of the disease. Thus the study was 
planned to study etiopathogenesis of the disease, and 
explore the better and safer treatment options for the 
management of this disease through Ayurvedic 
management. Madhumeha is a disease in which the 
patient voids excessive quantity of urine having 
concordance with Madhu i.e. of Kashaya and Madhura 
taste, Ruksha texture and honey like color. In 
Madhumeha, mainly the Vata and Kapha are 
predominant though the disease is Tridoshaj. The Vata 
may be provoked either directly by its etiological 
factors or by the Avarana of its path by Kapha, Pitta or 
other Dushyas. So, Vagbhata has classified the 
Madhumeha into two categories i.e. Dhatukshanajanya 
Madhumeha and Avarnajanya Madhumeha. Type I 
Diabetes mellitus is nearer to Dhatuakshanajanya 
Madhumeha while type II Diabetes mellitus resembles 
to Avaranajanya Madhumeha.  
 Among the 60 cases of diabetes mellitus the 
symptomatic distribution of weakness was 75%, i.e. 
highest, muscle cramps was 58.3% and joint pain was 
55%. In statistical data follow up of 1 month duration 
has been shown in table, so there are total 3 follow 
FU1, FU2 and last FU3 is AT i.e. is after treatment due 
to enlargement of data in 6 follow up. In subjective 
assessment of Group I (Madhumeha Nashini Gutika) 
symptomatically the result was highly significant 
(p>.001) in Polyuria, Weakness, Muscles cramps and 
joint pain. While it was significant in Polydipsia 
(p<.01), Polyphagia (<.01), Libido (p<.05) and 
Paduvarnmurata (p<.05). In objective assessment of 
Group I (Madhumeha Nashini Gutika) results based on 
laboratory investigations was highly significant 
(p<.001) in both BSF & BSPP. In subjective assessment 
of Group II (Darvyadi Kwath) symptomatically the 
result was highly significant (p>.001) in Weakness, 
Muscles cramps and joint pain. While it was significant 
in Polyuria (p<.05) Polydipsia (p<.01), Polyphagia 
(<.01), Libido (p<.05) and Paduvarnmurata (p<.05). In 
objective assessment of Group II (Darvyadi Kwath) 
results based on laboratory investigations was highly 
significant (p<.001) in BSF, while it was significant 
(p<.01) in case of BSPP. In subjective assessment of 
Group III (Madhumeha Nashini Gutika & Darvyadi 
Kwath) symptomatically the result was highly 
significant (p>.001) in Polyuria, Weakness, Muscles 
cramps and joint pain. While it was significant in 
Polydipsia (p<.01), Polyphagia (<.01), Libido (p<.05) 
and Paduvarn murata (p<.02). In objective assessment 
of Group III (Madhumeha Nashini Gutika & Darvyadi 
Kwath) results based on laboratory investigations was 
highly significant (p<.001) in both BSF & BSPP. While 
observing other biochemical parameters, (e.g. lipid 
profile, B. urea and S. Creatinine) significant reduction 
is found at the end of the trial. Not any kind of side 
effect was detected after the end of the trial of 90 days. 
Comparative assessment of improvement is 
also observed in all three groups. In Group I 
(Madhumeha Nashini Gutika) Marked Improvement 
was found in symptoms of muscles cramps and 
Panduvaran mutrata. In Group II (Darvyadi Kwath) 
Marked Improvement was found in symptoms of 
Polyuria, Polyphagia, Muscles cramps, joint pain and 
Panduvaran mutrata. In Group III (Madhumeha Nashini 
Gutika & Darvyadi Kwath) was found in all symptoms 
viz. Polyuria, Polyphagia, Polydipsia, Muscles cramps, 
Joint pain, weakness and Panduvaran mutrata. 
Probable mode of action of selected drugs 
 The first trial drug ‘Madhumeh Nashini Gutika’ 
is a herbo-mineral formulation; the constituents are 
Shilajeet, Trivang Bhasma (Naag, Vang and Yasad), 
Nimba and Gudmar. All the ingredients have 
documented hypoglycaemic activity and have been 
extensively studied in diabetic patients. ‘Trivang 
Bhasma’ is Kapha-Medohar, and contains the Tikta-
Kashaya ras by which it corrects vitiation of Kapha & 
Pitta. These three metals of Trivang bhasma also 
reduces the general weakness of body. The second 
constituent is ‘Gudmar’, which is Kapha-vatahar and 
contains Tikta Kashay ras. It contains alkaloids like 
gymnemagenin, gypenosies etc. Its dried leaf powder 
increased circulating insulin level and exhibited 
hypoglycaemic activity. The third constituent is 
‘Nimba’, which is Kapha-Pittahar and contains Tikt-
Kashay ras. Its leaves have chemicals like Azadirachtin, 
Azadirone, Nimbolide etc. Which effectively decrease 
blood sugar level and prevent hyperglycaemia. The 
fourth constitute is ‘Shilajeet’. It is a phytocomplex that 
contains over 85 minerals in their ionic form and 
triterpenes, selenium, phospholipids, humic acid and 
fulvic acid. These compounds have strong antioxidant 
properties which reduces degenerative changes in beta 
cells of pancreas, while the minerals help give Shilajeet 
an energy-enhancing effect. Most Shilajeet compounds 
contain between 60-80% fulvic acid, and the greater 
the content of fulvic acid, the more anti-aging 
properties the compound contains. It reduces Kapha 
due to Tikta ras, Katu vipak, Ushan virya, Shoshak and 
Chedaka properties and then it checks Mandagni and 
reduces Meda, which is the major factor (i.e. 
Medodushti) in pathogenesis of Madhumeh. Due to its 
Chedan property it expels the Kaphadi doshas from the 
Srotas with the force due to Prabhava of the drug. 
Chedana drugs are usually belonging to Amla, Katu rasa 
and Teekshna guna. On the other hand Chedana serves 
two fold functions. 1. Amla helps in vilayana of 
obstructive materials. 2. Katu & Tikta expels the 
vitiated material from the Srotas. With the above 
diathesis the obstructive Kapha and other material 
have been cleared out from the Srotas. Shilajeet is 
having the properties of Katu, Ushna virya, Ushna and 
Laghu so it acts Deepana. Katu rasa of Shilajeet 
stimulate the function of the Vyana. So the normalized 
functions of the stomach also help in digestion of Aam. 
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In this way the properties of all four contains of drug 
help in Samprapti Vighatan of the disease. 
The second trial drug is ‘Darvyadi Kwath’ 
consisting Devdaru, Daruhridra, Triphala and Musta. 
These drugs basically are Kashaya and Tikta Rasa 
pradhan, Ushna Veerya and Laghu Ruksha Guna, this 
formulation helps in eliminating vitiated kapha. It also 
corrects the vitiated both Medas and Kapha being the 
main entity of the Samprapti, thus by breaking the 
Samprapti (correcting the vitiation of Medas and 
Kapha) treats the disease. As the drug is Ushna it also 
increased improving the Dhatvagni, (as Ayurveda 
believes that the disease is Amajanya).  
CONCLUSIONS 
It can be concluded that Avaranjanya 
Madhumeha can be correlated with Diabetes mellitus 
type-II. An etiological factor vitiates mainly Kapha, Pitta 
and Meda causes excessive accumulation of morbid 
matter inside the body and obstructs the path of Vata. 
Due to Avarana aggravated Vata causes depletion of 
Vital Dhatu like Oja, Majja and Vasa and affect the 
normal physiology. Sedentary life, Lack of exercise, 
Faulty food habits and improper medication precipitate 
the disease. Treatment modalities based upon the 
consideration of vitiated Kapha, Meda and Vata having 
properties like Shleshamamedohara, Pramehaghna and 
Kapha-Vatahara.. After evaluating the total effect of 
therapies it was observed that the ‘Madhumeha 
Nashinh Gutika’ & Darvyadi Kwath (Combined therapy) 
provided better relief in the patients of Madhumeha in 
comparison to single group therapy. No any side effects 
were observed during treatment Though Diabetes is 
irreversible if established once. The complication of 
Diabetes mellitus and side effects can be controlled on 
prevented with the best use of Ayurvedic medicine. 
Thus we are very happy indeed to declare our highly 
encouraging results regarding the successfully treated 
cases. we sincerely hope and wish that the presented 
study shall always be pioneers an ideal research work 
for the coming generation. 
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